Weight-Loss Drugs Outperform Older Diabetes Pills in People with HIV, Real-World Study Finds
A nine-site U.S. cohort study found that GLP-1 receptor agonists produced roughly four times more weight loss than SGLT2 inhibitors ...
A nine-site U.S. cohort study found that GLP-1 receptor agonists produced roughly four times more weight loss than SGLT2 inhibitors ...
A post hoc analysis of the SURMOUNT-OSA trials shows that losing at least 10 percent of body weight within the ...
A machine learning model combining baseline gut microbiome profiles with clinical variables can predict who sustains weight loss twelve weeks ...
Post hoc analyses of the SURMOUNT-OSA trials show tirzepatide improved sleep apnea severity, weight, and blood pressure across all baseline ...
New analyses of nintedanib clinical trials reveal that unintentional weight loss sharply accelerates lung function decline in patients with pulmonary ...
A real-world surveillance study of 259 Taiwanese adults with obesity found that liraglutide produced clinically significant weight loss and a ...
A meta-analysis of 19 high-potency incretin trials finds that objective signs of malnutrition and lean mass loss occur far more ...
A comparative narrative review finds tirzepatide delivers the largest HbA1c and weight reductions among incretin therapies, while semaglutide leads on ...
A case report from Peking Union Medical College Hospital describes a rare triple comorbidity of anorexia nervosa, PTSD, and chronic ...
Exit interviews with 74 long-term participants in the SURPASS-CVOT trial reveal that tirzepatide and dulaglutide produced perceived benefits in glycemic ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine